Valuation: 10x Genomics, Inc.

Market Cap 9.47B 8.21B 7.76B 7.04B 13.2B 908B 13.28B 92.6B 35.78B 461B 35.57B 34.78B 1,469B P/E 2026 *
-101x
P/E 2027 * -105x
Enterprise Value 9B 7.8B 7.38B 6.7B 12.55B 864B 12.62B 88.05B 34.02B 438B 33.83B 33.07B 1,397B EV / Sales 2026 *
14.5x
EV / Sales 2027 * 13.2x
Free-Float
90.92%
Yield 2026 *
-
Yield 2027 * -
1 day-2.30%
1 week+8.01%
Current month+16.38%
1 month+29.58%
3 months+128.91%
6 months+335.47%
Current year+345.62%
1 week 64.73
Extreme 64.73
77.87
1 month 55.25
Extreme 55.25
77.87
Current year 15.9
Extreme 15.9
77.87
1 year 11.16
Extreme 11.16
77.87
3 years 6.78
Extreme 6.78
77.87
5 years 6.78
Extreme 6.78
187.85
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/26 Sell

Chief Financial Officer

-46,388 0.0386%
9/3/26 Sell

Chairman

-20,000 0.0166%
9/1/26 Don

Founder

-100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%+8.01%+453.54%+46.15% 9.47B
-0.43%+7.45%+215.70%+492.28% 23.47B
-0.48%+1.05%-36.11%-21.16% 9.84B
-1.02%+17.39%-16.19% - 7.97B
-0.19%-0.16%+93.42%+55.13% 6.56B
+0.04%-0.35%-28.91%-24.66% 5.74B
+1.48%+1.73%-3.49%-18.28% 4.3B
+0.81%-8.36%+53.44%+63.10% 3.74B
+0.57%-0.47%-22.25%-31.21% 2.72B
+0.22%-13.96% - - 1.57B
Average -0.22%+3.62%+78.80%+70.17% 7.54B
Weighted average by Cap. -0.47%+5.37%+127.96%+183.41%

Financials

2026 *2027 *
Net sales 620M 537M 508M 461M 864M 59.48B 869M 6.06B 2.34B 30.17B 2.33B 2.28B 96.16B 680M 589M 557M 506M 948M 65.24B 953M 6.65B 2.57B 33.09B 2.55B 2.5B 105B
Net income -94.29M -81.71M -77.23M -70.12M -131M -9.05B -132M -922M -356M -4.59B -354M -346M -14.62B -88.67M -76.84M -72.63M -65.93M -124M -8.51B -124M -867M -335M -4.31B -333M -326M -13.75B
Net Debt -465M -403M -381M -346M -648M -44.61B -652M -4.55B -1.76B -22.63B -1.75B -1.71B -72.12B -521M -451M -427M -387M -726M -49.97B -730M -5.09B -1.97B -25.35B -1.96B -1.91B -80.79B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.
Employees
1,178
Date Price Change Volume
26-09-16 US$72.68 -2.30% 4,082,634
26-09-15 US$74.39 +6.10% 2,905,279
26-09-14 US$70.11 +2.22% 3,364,058
26-09-11 US$68.59 +3.33% 1,829,696
26-09-10 US$66.38 -1.35% 2,436,093
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
72.68USD
Average target price
52.13USD
Spread / Average Target
-28.27%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!